The Russian invasion of Ukraine has caused a huge humanitarian crisis, unprecedented in the modern era of the European continent. Responding to the needs of the Ukrainian people, individuals, companies and governments from at least 29 European countries took action by sending humanitarian aid to Ukraine, mainly through the EU Civil Protection Mechanism. IASIS PHARMA [...]
Kastri, Athens, 4/2/2022 Even more increased, concerning both its members and its activities compared to the previous year, IASIS PHARMA held its new year’s cake cutting event on Friday, February 4, 2022. The event took place in Kastri, Athens, complying to the measures against COVID-19 and with all of its personnel fully vaccinated, who had [...]
www.hyper-mastic.eu - Facebook: Hyper-Mastic Focusing on the study of the Greek nature, IASIS PHARMA is glad to announce the launch of HYPER-MASTIC, a scientific research project to be carried out in cooperation with a team of Academic and Corporate entities. The project members are: - IASIS PHARMA a pharmaceutical industry - Chios Gum Mastic Growers Association [...]
IASIS PHARMA expands its activities focusing on Greek nature, collaborating in the establishment of Natural Products Competence Center (NPCC). NPCC is a Collaborative Innovation Formation, with the participation of 15 partners from the academic and business sectors. The project is coordinated by the Laboratory for the Utilization of Bioactive Natural Products (Department of Pharmacy, National [...]
Construction activities at the Chios Mastic Research and Development Center continue at an intensive pace, most recent being the completion of the air conditioning & ventilation systems. Since the project started, the basic intention of the facilities’ design was its typological differentiation from a "typical" industrial facility, but at the same time meeting pharmaceutical industry [...]
Winter vacation period has just ended, also affected by covid-19 pandemic. Nevertheless, IASIS PHARMA stayed focused on its corporate responsibility, in order all employees return to their jobs safely. More specifically, before their return, all IASIS PHARMA employees were re-tested for covid-19. The tests were carried out by a well-established private clinic at IASIS PHARMA [...]
IASIS PHARMA, compliant to its social corporate responsibility, after the free-of-charge production of 28.700lt of antiseptic solution for the Greek public health system, this time and in order all IASIS PHARMA employees to return to their jobs as safely as possible, carried out several pre-planned actions: - All IASIS PHARMA employees passed from covid-19 tests. [...]
For the extremely demanding pharmaceutical form of effervescent tablets, IASIS PHARMA chooses IMA technology, to combine top of the line quality with very high production capacity. IASIS PHARMA brand new pharma grade effervescent manufacturing facility is part of its second, 45.000m2 manufacturing site that became operational in 2019, in Koropi, Athens. The effervescent manufacturing facility is a [...]
The pandemic that was spread by COVID-19, apart from the irreplaceable loss of human life, also caused several shocks to the global economy and entrepreneurship. Nevertheless, under the auspices of the Panhellenic Association of Pharmaceutical Industry (PEF), Greek pharmaceutical companies stepped in to support both the Greek State and the patients. IASIS PHARMA played a [...]
During the past months, Greece, just like the rest of the world, faced an unprecedented health crisis· COVID-19 corona virus pandemic, in addition to the irreplaceable loss of human life, has caused extremely adverse conditions in all areas of the economy and entrepreneurship. Nevertheless, the Greek pharmaceutical industry not only endured that situation, but took [...]
